These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Role of Histamine-releasing Factor in Allergic Inflammatory Reactions]. Kashiwakura JI; Ando T; Kawakami T Yakugaku Zasshi; 2017; 137(5):517-521. PubMed ID: 28458281 [TBL] [Abstract][Full Text] [Related]
4. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease. Gomez G Front Immunol; 2019; 10():175. PubMed ID: 30792720 [TBL] [Abstract][Full Text] [Related]
5. Mapping of the CD23 binding site on immunoglobulin E (IgE) and allosteric control of the IgE-Fc epsilonRI interaction. Borthakur S; Hibbert RG; Pang MO; Yahya N; Bax HJ; Kao MW; Cooper AM; Beavil AJ; Sutton BJ; Gould HJ; McDonnell JM J Biol Chem; 2012 Sep; 287(37):31457-61. PubMed ID: 22815482 [TBL] [Abstract][Full Text] [Related]
11. IgE and IgA produced by OX40-OX40L or CD40-CD40L interaction in B cells-mast cells re-activate FcεRI or FcαRI on mast cells in mouse allergic asthma. Hong GU; Lim JY; Kim NG; Shin JH; Ro JY Eur J Pharmacol; 2015 May; 754():199-210. PubMed ID: 25704619 [TBL] [Abstract][Full Text] [Related]
12. Antibody to FcεRIα Suppresses Immunoglobulin E Binding to High-Affinity Receptor I in Allergic Inflammation. Hong JY; Bae JH; Lee KE; Kim M; Kim MH; Kang HJ; Park EH; Yoo KS; Jeong SK; Kim KW; Kim KE; Sohn MH Yonsei Med J; 2016 Nov; 57(6):1412-9. PubMed ID: 27593869 [TBL] [Abstract][Full Text] [Related]
13. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils. Song Y; Qu C; Srivastava K; Yang N; Busse P; Zhao W; Li XM J Allergy Clin Immunol; 2010 Dec; 126(6):1208-17.e3. PubMed ID: 21134573 [TBL] [Abstract][Full Text] [Related]
15. SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response. Sharma N; Ponce M; Kaul S; Pan Z; Berry DM; Eiwegger T; McGlade CJ Front Immunol; 2019; 10():1020. PubMed ID: 31156621 [TBL] [Abstract][Full Text] [Related]
16. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E. Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203 [TBL] [Abstract][Full Text] [Related]
17. The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis. Galli SJ Am J Pathol; 2016 Feb; 186(2):212-24. PubMed ID: 26776074 [TBL] [Abstract][Full Text] [Related]